City Journal's 10 Blocks
joins to discuss politics and public safety in the City by the Bay.
info_outline Parenting Under the InfluenceCity Journal's 10 Blocks
joins to discuss the impact of drug use and decriminalization on children.
info_outline Cultivating CivilityCity Journal's 10 Blocks
joins to discuss her book .
info_outline Chaos CoordinatorsCity Journal's 10 Blocks
joins to discuss his documentary It Wasn't Fauci: How the Deep State Really Played Trump.
info_outline Gondola DodgersCity Journal's 10 Blocks
joins to discuss the controversial plan to install an aerial transit system connecting Los Angeles’s Dodger Stadium to the city.
info_outline The Will to LibertyCity Journal's 10 Blocks
joins to discuss how we can transcend the pettiness and corruption of our current political moment.
info_outline Harvard’s Unscientific ConsensusCity Journal's 10 Blocks
joins to discuss his firing from Harvard University and the importance of scientific debate.
info_outline Abundance or Extinction?City Journal's 10 Blocks
joins to discuss the potential and danger of artificial intelligence.
info_outline The Future of MobilityCity Journal's 10 Blocks
joins to discuss autonomous vehicles’ potential to remake transportation.
info_outline Chaos and OrderCity Journal's 10 Blocks
joins to discuss his book .
info_outlineJohn Tierney joins City Journal editor Brian Anderson to discuss what the debate over prescription drugs gets wrong and the cost that government-imposed price controls could have on one of the world's most innovative industries.
The business practices of the pharmaceutical industry--or "Big Pharma"—are one of the most divisive political issues of our time. Leaders from both political parties, from Bernie Sanders to President Trump, regularly denounce drug companies for profiteering and call for lower drug prices. But as Tierney notes in City Journal, "of every dollar that Americans spend on health, only a dime goes for prescription drugs. The lion's share of health spending goes to hospitals and people in the health-care professions."
America has been called the "Pharmacy to the World" because it's where more than half of new drugs get developed and tested in clinical trials. Patients in Europe and elsewhere enjoy the benefits of these breakthrough drugs. Price controls in the U.S. would significantly curtail new research and development projects--resulting in a net loss for everyone.